Clinical Trials Browser

Phase 1/2 × Small Cell Lung Carcinoma × lutetium Lu 177 dotatate × Clear all

NCT03325816 2021-03-16

Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer

Phase 1/2 Completed

9 enrolled 10 charts

Small Cell Lung Carcinoma